Aliskiren Combination patent revoked in India


Aliskiren is, a renin inhibitor, marketed by Novartis.

Aliskiren combination is protected by WO2002040007 and its equivalent patent is granted in India  [212199  (724/cHENP/2003)].

The  ‘199 patent is revoked in post grant opposition filed by Sun Pharma

Decision is available at IPAIRS

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s